Cellular eukaryotic initiation factor 5A content as a mediator of polyamine effects on growth and apoptosis

NeuroSignals

Volumn 6, Issue 3, 1997, Pages 150-156

  Tome, Margaret E ^a   Gerner, Eugene W ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Apoptosis; Cell growth; eIF 5A; Polyamines; Putrescine

Indexed keywords

HYPUSINE; INITIATION FACTOR; INITIATION FACTOR 5A; POLYAMINE; PUTRESCINE; SPERMIDINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ETIOLOGY; EUKARYOTIC CELL; NONHUMAN; POLYAMINE METABOLISM; PROTEIN PROCESSING; REVIEW;

ANIMALS; APOPTOSIS; CELL DIVISION; HUMANS; LYSINE; PEPTIDE INITIATION FACTORS; PUTRESCINE; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION;

ANIMALIA; EUKARYOTA;

EID: 0030815058     PISSN: 1424862X     EISSN: 14248638     Source Type: Journal    
DOI: 10.1159/000109121     Document Type: Article

References (50)

1. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988;48:759-774.
2. Davis RH: Management of polyamine pools and the regulation of ornithine decarboxylase. J Cell Bio-chem 1990;44:199-205.
3. Marton U, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995; 35:55-91.
4. Brunton VG, Grant HM, Wallace HM: Mechanisms of spermine toxicity in baby-hamster kidney (BHK) cells. Biochcm J 1991;280:193-198.
5. Mitchell JLA, Divcley RR Jr, Bar-cyal-Leyser A, Mitchell JL: Abnormal accumulation and toxicity of polyamines in a difiuoromethylomi-thinc-rcsistanl HTC cell variant. Biochim Biophys Acta 1992,1136: 136-142.
6. Tome ME, Fiser SM, Gemer EW: Consequences of aberrant ornithine decarboxylase regulation in rat hepatoma cells. J Cell Physiol 1994; 158: 237-244.
7. Tobias KE, Kahana C: Exposure to ornithine results in excessive accumulation of putrcscine and apoptot-ic cell death in ornithine decarboxylase overproducing mouse myeloma cells. Cell Growth Differ 1995:6: 1279-1285.
8. Davis RH, Morris DR. Coffino P: Sequestered end products: The case of ornithine decarboxylase. Microbiol Rev 1992;56:280-290.
9. e-(4-amino-2-hydroxybutvl)-lysine). J Biol Chem 1982;257: 7217-7222.
10. Park MH, Wolff EC: Cell-free synthesis of dcoxyhypusine. J Biol Chem 1988;263:15264-15269.
11. Park MH, Cooper HL, Folk JE: Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc Natl Acad Sci USA 1981;78: 2869-2873.
12. Sano A: Purification of hypusinc-containing protein from rat liver, in Imahori K, Suzuki F. Suzuki O, Bachrach U (eds): Polyamines: Basic and Clinical Aspects. Utrecht, VNU Sciences Press, 1985, pp 81-88.
13. + as translation initiation factor elF-4D. Proc Natl Acad Sci USA 1983:80:1854-1857.
14. Park MH, Chung SI, Cooper HL, Folk JE: The mammalian hypusine-containing protein, eucaryotic initiation factor 4D. J Biol Chem 1984; 259:4563-4565.
15. Park MH, Wolff EC, Smit-McBride Z, Hershey JWB, Folk JE: Comparison of the activities of the variant forms of cIF-4D. J Biol Chem 1991; 266:7988-7994.
16. Cooper HL, Park MH, Folk JE: Posttranslational formation of hypusine in a single major protein occurs generally in growing cells and is associated with activation of lymphocyte growth. Cell 1982;29:791-797.
17. Chen K.Y: An 18,000-dalton protein mctabolically labelled by polyamines in various mammalian cell lines. Biochim Biophys Acta 1983; 756:395-402.
18. Torrelio BM, Paz MA, Gallop MP: Cellular proliferation and hypusine synthesis. Exp Cell Res 1984; 154: 454-463.
19. Duncan RF. Hershey JWB: Changes in cF-4D hypusine modification or abundance are not correlated with translational repression in HcLa cells. J Biol Chem 1986;261:12903-12906.
20. Gemer EW, Marnont PS, Bernhardt A, Siat M: Post-translational modification of the protein synthesis initiation factor elF-4D by spermidine in rat hepatoma cells. Biochem J 1986; 239:379-386.
21. Park MH, Wolff EC, Lee YB, Folk JE: Antiproliferative effects of inhibitors of dcoxyhypusine synthase. J Biol Chem 1994;269:27827-27832.
22. Chen ZP, Yan YP, Ding QJ, Knapp S, Potenza JA, Schugar HJ, Chen KY: Effects of inhibitors of dcoxy-hypusine synthase on the differentiation of mouse neuroblastoma and erythroleukemia cells. Cancer Lett 1996;105:233-239.
23. Hanauskc-Abel HM, Park MH, Ha-nauske A-R, Popowiez AM, Lalande M, Folk JE: Inhibition of the Gi-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim Biophys Acta 1994; 1221:115-124.
24. Mehta K, Leung D, Lefebvre L, Smith M: The ANB1 locus of Saccharomyces cerevisiae encodes the protein synthesis initiation factor eIF-4D. J Biol Chem 1990;265: 8802-8807.
25. Schnier J, Schwelberger HG, Smit-McBride Z, Kang HA, Hershey JWB: Translation initiation factor 5A and its hypusine modification arc essential for cell viability in yeast Saccharomyces cerevisiae. Mol Cell Biol 1991;11:3105-3114.
26. Schwelberger HG, Kang AH, Her-shey JWB: Translation initiation factor cIF-5A expressed from cither of two yeast genes or from human cDNA. J Biol Chem 1993;268: 14018-14025.
27. Kang HA, Hershey JWB: Effect of initiation factor clF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem 1994;269:3934-3940.
28. Sasaki K, Abid MR, Miyazaki M: Deoxyhypusine synthase gene is essentia) for cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett 1996:384:151-154.
29. Park MH: Regulation of biosynthesis of hypusine in Chinese hamster ovary cells. J Biol Chem 1987:262: 12730-12734.
30. Park MH, Wolff EC, Folk JE: Hypu-sinc: Its post-translational formation in cucaryotic initiation factor 5Aand its potential role in cellular regulation. Biofactors 1993;4:95-104.
31. Bevec D, Klier H, Holter W, Tschachler E, Valent P, Lottspeich F, Baumrucker T, Hauber J: Induced gene expression of tl:c hypu-sine-containing protein eucaryotic initiation factor 5A in activated human T lymphocytes. Proc Natl Acad Sei USA 1994;91:10829-10833.
32. Pang JH, Chen KY: Global change of gene expression at late G/S boundary may occur in human IMR-90 diploid fibroblasts during senescence. J Cell Physiol 1994; 160: 531-538.
33. Mitchell JLA, Hoff JA, Barcyal-Leyser A: Stable ornithine decarboxylase in a rat hepatoma cell line selected for resistance to a-difiuor-omethylomithine. Arch Biochcm Biophys 1991;290:143-152.
34. Tome ME, Gemer EW: Hypusine modification in cucaryotic initiation factor 5A in rodent cells selected for resistance to growth inhibition by ornithine decarboxylase-inhibiting drugs. Biochem J 1996:320:55-60.
35. Byers TL, Ganem B, Pegg AE: Cy-tostasis induced in L1210 murine leukaemia cells by the S-adenosyl-L-mcthionine dcarboxylase inhibitor 5'-[(Z)-4-amino-2-butcnyl]mcthyl-amino]-5'-deoxyadenosine may be due to hypusine depletion. Biochem J 1992;287:717-724.
36. Byers TL, Weist L, Wechter RS, Pegg AE: Effects of chronic 5'-([(Z)-4 - amino - 2 - bu tenyl] met hylamino) -5'-dcoxyadcnosinc (AbeAdo) treatment on polyamine and eIF-5A metabolism in AbeAdo-sensitive and -resistant L1210 murine leukemia cells. Biochem J 1993,290:115-121.
37. Byers TL, Lakanem JR, Coward J K, Pegg AE: The role of hypusine depletion in cytostasis induced by S-adenosyl-L-rncthionine decarboxylase inhibition: New evidence provided by l-methylspermidine and 1,12-dimethylspermine. Biochem J 1994;303:363-368.
38. Seiler N: Pharmacological properties of the natural polyamines and their depletion by biosynthesis inhibitors as a therapeutic approach; in Jucker E (ed): Progress in Drug Research. Basel, Birkhauser, 1991, vol 37, pp 107-159.
39. Xie X, Tome ME, Gemer EW: Loss of intracellular putrcscinc pool-size regulation induces apoptosis. Exp Cell Res 1997;230:386-392.
40. Tabor CW, Tabor H, Bachrach U: Identification of the aminoalde-hydes produced by the oxidation of spermine and spermidine with purified plasma amine oxidase. J Biol Chem 1964;239:2194-2203.
41. Kimes BW, Morris DR; Preparation and stability of oxidized polyamines. Biochim Biophys Acta 1971;228:223-234.
42. Packham G, Cleveland JL: Ornithine decarboxylase is a mediator of c-wyc-induccd apoptosis. Mol Cell Biol 1994;14:5741-5747.
43. McCloskey DE, Casero RA Jr, Wos-ter PM, Davidson NE: Induction of programmed cell death in human breast cancer cells by an unsymme-trically alkylated polyaminc analog. Cancer Res 1995;55:3233-3236.
44. Gahl WA, Pilot HC: Reversal by aminoguanidine of the inhibition of proliferation of human fibroblasts by spermidine and spermine. Chem Biol Interact 1978;22:91-98.
45. Davis RH, Ristow JL: Polyamine toxicity in Neurospora crassa: Protective role of the vacuole. Arch Bio-cliem Biophys 1991;285:306-311.
46. Guarino LA, Cohen SS: Mechanism of toxicity in Anacysiis nidulans. Proc Natl Acad Sei USA 1979:76: 3660-3664.
47. Kimes BW, Morris DR: Cations and ribosome structure U: Effects on the 50S subunit of substituting polyamines for magnesium ion. Biochemistry 1973;12:442-449.
48. Jakus J, Wolff EC, Park MH, Folk JE: Features of the spermidine-binding site of deoxyhypusine synthetase as derived from inhibition studies. J Biol Chem 1993,268:13151 -13159.
49. Hanauskc-Abel HM, Slowinska B, Zagulska S, Wilson RC, Staiano-Coico L, Hanauskc A-R, McCaffrey T, Szabo P: Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the Gi-S boundary - proposal of a role for clF-5A in onset of DNA replication. FEBS Lett 1995;366: 92-98.
50. Oren M: Relationship of p53 to the control of apoptotic cell death. Scm Cancer Biol 1994;5:221-227.